Joseph Michael Fitzgerald, EVP & Group President, Cardiology at BOSTON SCIENTIFIC CORP (BSX), sold 96,400 shares at $99.76 ($9.6M) on 2025-11-03, disclosed to the SEC on 2025-11-04.
Scheduled sale ($9.6M) by EVP & Group President, Cardiology under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $99.14 | 29,472 | $2.9M | 30.5% |
| 2 | $99.14 | 29,472 | $2.9M | 30.5% |
| 3 | $99.76 | 16,928 | $1.7M | 17.6% |
| 4 | $99.76 | 16,928 | $1.7M | 17.6% |
| 5 | $100.75 | 3,600 | $363K | 3.8% |
| Total | $99.42 avg | 96,400 |
| $9.6M |
| 100% |
| Filing → |
| BSX | SELL | 2025-08-04 | $5.2M | — | Filing → |
| BSX | SELL | 2025-07-02 | $5.3M | — | Filing → |
| BSX | SELL | 2025-06-04 | $11.6M | — | Filing → |